To do 45M in 2006. The latest update, had Dacogen at 34% of the market. The CEO stated Dacogen was growing at double digit's and competitors drug was falling at single digits. Anything above 40M will be great news. Would like to see Nipent EU completed. Any update on Mayne sale?
I calculated this from latest update that dacogen has captured 34% of the market. Latest numbers are 30M+ and CEO of supg stated significant more hopeful. Looks like they're above 1150 vials a week @ $1,500 per vial. That puts sales around 1.7M per week. It would be a stetch to hit the 45M, however 37-40M should be the number.